论文信息 - Preliminary Safety and Efficacy Results with an Intermittent Schedule of the PI3kδ Inhibitor ME-401 Alone or in Combination with Rituximab for B-Cell Malignancies - 字舞流文

Preliminary Safety and Efficacy Results with an Intermittent Schedule of the PI3kδ Inhibitor ME-401 Alone or in Combination with Rituximab for B-Cell Malignancies

A. Zelenetz | A. Iasonos | A. Stathis | J. Pagel | R. Ghalie | A. Asch | V. Kenkre | D. Jagadeesh | J. Soumerai | N. Reddy | H. Salman | H. Jhangiani | Patel Krish